Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dane Cheasley

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Briefings in Bioinformatics|May 24, 2026
A scalable, multi-resolution consensus clustering approach for prioritizing robust signals from high-throughput screensShaine Chenxin Bao, Kathleen I Pishas, Karla J Cowley, et al.
NPJ Breast Cancer|June 12, 2021
Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control studyNa Li, Belle W X Lim, Ella R Thompson, et al.
International Journal of Molecular Sciences|February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational StatusMadison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Journal of the National Cancer Institute|April 6, 2019
Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast CancerNa Li, Simone McInerny, Magnus Zethoven, et al.
NPJ Breast Cancer|August 18, 2020
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic densityDane Cheasley, Lisa Devereux, Siobhan Hughes, et al.
Cancers|November 27, 2021
Phenotypic Consequences of <i>SLC25A40-ABCB1</i> Fusions beyond Drug Resistance in High-Grade Serous Ovarian CancerKathleen I Pishas, Karla J Cowley, Ahwan Pandey, et al.
NPJ Breast Cancer|March 21, 2020
The genetic architecture of breast papillary lesions as a predictor of progression to carcinomaTanjina Kader, Kenneth Elder, Magnus Zethoven, et al.
NPJ Precision Oncology|June 29, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expressionDane Cheasley, Marta Llaurado Fernandez, Martin Köbel, et al.
The Journal of Pathology|September 9, 2020
Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilitiesDane Cheasley, Abhimanyu Nigam, Magnus Zethoven, et al.
The Journal of Pathology|May 15, 2026
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profileKathleen I Pishas, Karla J Cowley, Evanny Marinovic, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Briefings in Bioinformatics|May 24, 2026
A scalable, multi-resolution consensus clustering approach for prioritizing robust signals from high-throughput screensShaine Chenxin Bao, Kathleen I Pishas, Karla J Cowley, et al.
NPJ Breast Cancer|June 12, 2021
Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control studyNa Li, Belle W X Lim, Ella R Thompson, et al.
International Journal of Molecular Sciences|February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational StatusMadison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Journal of the National Cancer Institute|April 6, 2019
Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast CancerNa Li, Simone McInerny, Magnus Zethoven, et al.
NPJ Breast Cancer|August 18, 2020
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic densityDane Cheasley, Lisa Devereux, Siobhan Hughes, et al.
Cancers|November 27, 2021
Phenotypic Consequences of <i>SLC25A40-ABCB1</i> Fusions beyond Drug Resistance in High-Grade Serous Ovarian CancerKathleen I Pishas, Karla J Cowley, Ahwan Pandey, et al.
NPJ Breast Cancer|March 21, 2020
The genetic architecture of breast papillary lesions as a predictor of progression to carcinomaTanjina Kader, Kenneth Elder, Magnus Zethoven, et al.
NPJ Precision Oncology|June 29, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expressionDane Cheasley, Marta Llaurado Fernandez, Martin Köbel, et al.
The Journal of Pathology|September 9, 2020
Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilitiesDane Cheasley, Abhimanyu Nigam, Magnus Zethoven, et al.
The Journal of Pathology|May 15, 2026
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profileKathleen I Pishas, Karla J Cowley, Evanny Marinovic, et al.
Pageof 3